REGN Covered Calls: Premium Income for Regeneron Pharmaceuticals
Regeneron Pharmaceuticals develops blockbuster biologics including Dupixent and Eylea. Very high IV from binary drug approval events creates premium-rich covered call setups.
Regeneron Pharmaceuticals develops blockbuster biologics including Dupixent and Eylea. Very high IV from binary drug approval events creates premium-rich covered call setups.